We are live on ! Find out more
SBRA icon

Sabra Healthcare REIT

318 hedge funds and large institutions have $2.58B invested in Sabra Healthcare REIT in 2020 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 119 increasing their positions, 93 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

342% more call options, than puts

Call options by funds: $4.94M | Put options by funds: $1.12M

28% more repeat investments, than reductions

Existing positions increased: 119 | Existing positions reduced: 93

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

15% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 34

0% more funds holding

Funds holding: 317318 (+1)

0.21% less ownership

Funds ownership: 91.27%91.06% (-0.21%)

5% less capital invested

Capital invested by funds: $2.71B → $2.58B (-$127M)

Holders
318
Holders Change
+1
Holders Change %
+0.32%
% of All Funds
6.42%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.1%
New
39
Increased
119
Reduced
93
Closed
34
Calls
$4.94M
Puts
$1.12M
Net Calls
+$3.82M
Net Calls Change
+$2.06M
Name Holding Trade Value Shares
Change
Change in
Stake
ANI
226
American National Insurance
Texas
$154K
ACM
227
AlphaCrest Capital Management
New York
$151K +$161K +10,947 New
MCM
228
McMillion Capital Management
North Carolina
$148K
PRC
229
Pearl River Capital
Michigan
$148K +$158K +10,754 New
Baird Financial Group
230
Baird Financial Group
Wisconsin
$147K +$156K +10,652 New
FRM
231
Fox Run Management
Connecticut
$144K +$153K +10,444 New
LIA
232
LS Investment Advisors
Michigan
$141K
TC
233
TwinBeech Capital
New York
$141K +$151K +10,254 New
Cetera Investment Advisers
234
Cetera Investment Advisers
Illinois
$140K +$149K +10,133 New
CC
235
Centiva Capital
New York
$139K +$148K +10,089 New
AssetMark Inc
236
AssetMark Inc
California
$134K +$69.5K +4,735 +95%
SAM
237
Storebrand Asset Management
Norway
$121K
QT
238
Quantbot Technologies
New York
$105K +$112K +7,646 New
TFS
239
TrustCore Financial Services
Tennessee
$104K +$3.44K +234 +3%
VanEck Associates
240
VanEck Associates
New York
$85K +$17.3K +1,177 +23%
FDCDDQ
241
Federation des caisses Desjardins du Quebec
Quebec, Canada
$82.8K
US Bancorp
242
US Bancorp
Minnesota
$66K -$17.4K -1,188 -20%
Ohio Public Employees Retirement System (OPERS)
243
Ohio Public Employees Retirement System (OPERS)
Ohio
$64K -$1.29M -88,011 -95%
RE
244
RBC Europe
United Kingdom
$61.3K +$58.3K +3,968 +827%
APA
245
American Portfolios Advisors
New York
$50.4K
CG
246
Cutler Group
California
$39K -$5.88K -400 -12%
CI Investments Inc
247
CI Investments Inc
Ontario, Canada
$39K +$41.6K +2,830 New
Lazard Asset Management
248
Lazard Asset Management
New York
$38K +$8.53K +581 +26%
NFG
249
Next Financial Group
Texas
$37K +$39.8K +2,710 New
PHK
250
Point72 Hong Kong
Hong Kong
$33K -$127K -8,635 -78%

SBRA Hedge Fund Activity: Q3 2020 in Review

318 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT (SBRA) for Q3 2020, worth a combined $2.58B — down 4.7% from $2.71B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new SBRA positions and 34 closed out — a net gain of 5 holders — while 119 added to existing stakes and 93 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $29.6M. The largest seller was Cohen & Steers, cutting an estimated $56.4M.

  • 318 institutional investors held Sabra Healthcare REIT (SBRA) as of Q3 2020, up from 317 in Q2 2020.
  • Funds reported $2.58B of Sabra Healthcare REIT stock for Q3 2020, down 4.7% quarter-over-quarter.
  • 39 funds opened new Sabra Healthcare REIT positions in Q3 2020 and 34 closed out, a net change of +5 holders.
  • The largest Sabra Healthcare REIT buyer in Q3 2020 was Janus Henderson Group, an estimated $29.6M added.
  • The largest Sabra Healthcare REIT seller in Q3 2020 was Cohen & Steers, an estimated $56.4M sold.

Based on aggregated 13F filings for Q3 2020.